Patent · US Expired

Semaphorin K1

US6583277B2 · kind B2 · utility

5Cited by
1References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 26, 2001
Grant dateJun 24, 2003
Priority date—
Expiry dateJul 9, 2021

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides methods and compositions relating to semaphorin K1 (sema K1) polypeptides which regulate cellular guidance and physiology, and related nucleic acids. The polypeptides may be produced recombinantly from transformed host cells from the disclosed sema K1 encoding nucleic acids or purified from human cells. The invention provides isolated sema K1 hybridization probes and primers capable of specifically hybridizing with the disclosed sema K1 genes, sema K1-specific binding agents such as specific antibodies, and methods of making and using the subject compositions in diagnosis, therapy and in the biopharmaceutical industry.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.